Risk factors for the incidence of breast cancer: Do they affect survival from the disease?

被引:139
作者
Barnett, Gillian C. [1 ]
Shah, Mitul
Redman, Karen
Easton, Douglas F.
Ponder, Bruce A. J.
Pharoah, Paul D. P.
机构
[1] Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England
关键词
D O I
10.1200/JCO.2006.10.3168
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Risk factors that influence the incidence of breast cancer may also affect survival after diagnosis. Methods Data from 4,560 women with invasive breast cancer who had taken part in the population-based Studies of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) breast cancer study were used to investigate the influence on survival of variables related to pregnancy, menarche and menopause, prior use of exogenous hormones, height, weight, body mass index (BMI), smoking history, and alcohol intake. Results In univariate analyses, there was no association between prognosis and age at menarche and menopause, menopausal status at diagnosis, smoking history, or prior use of the oral contraceptive pill. Women whose most recent pregnancy was more than 30 years ago had a 35% reduced risk of dying (95% CI, 8% to 54%) compared with women who had a full-term pregnancy in the past 15 years, and the use of hormone replacement therapy for more than 4 years was associated with a similar risk reduction. BMI was associated with a 3% (95% CI, 1% to 4%) increase in mortality per unit increase. Improved prognosis was seen with increasing current alcohol consumption, with a 2% (95% CI, 1% to 3%) reduction in the risk of death per unit of alcohol consumed per week. Conclusion The apparent benefit of alcohol intake has not been described before, and our data need to be interpreted with some caution. However, our finding that an increase in BMI is associated with a poorer prognosis supports previously published data and suggests that advice on weight loss should be given to all obese patients with breast cancer.
引用
收藏
页码:3310 / 3316
页数:7
相关论文
共 54 条
  • [31] Adiposity and sex hormones in postmenopausal breast cancer survivors
    McTiernan, A
    Rajan, KB
    Tworoger, SS
    Irwin, M
    Bernstein, L
    Baumgartner, R
    Gilliland, F
    Stanczyk, FZ
    Yasui, Y
    Ballard-Barbash, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1961 - 1966
  • [32] BODY SIZE, REPRODUCTIVE FACTORS, AND BREAST-CANCER SURVIVAL
    MOHLEBOETANI, JC
    GROSSER, S
    WHITTEMORE, AS
    MALEC, M
    KAMPERT, JB
    PAFFENBARGER, RS
    [J]. PREVENTIVE MEDICINE, 1988, 17 (05) : 634 - 642
  • [33] Hormone replacement therapy and the risk of death from breast cancer: A systematic review
    Nanda, K
    Bastian, LA
    Schulz, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (02) : 325 - 334
  • [34] Relation of time since last birth and parity to survival of young women with breast cancer
    Olson, SH
    Zauber, AG
    Tang, J
    Harlap, S
    [J]. EPIDEMIOLOGY, 1998, 9 (06) : 669 - 671
  • [35] PAPATESTAS AE, 1980, CANCER, V45, P191, DOI 10.1002/1097-0142(19800101)45:1<191::AID-CNCR2820450130>3.0.CO
  • [36] 2-6
  • [37] Prognosis of premenopausal breast cancer and childbirth prior to diagnosis
    Phillips, KA
    Milne, RL
    Friedlander, ML
    Jenkins, MA
    McCredie, MRE
    Giles, GG
    Hopper, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) : 699 - 705
  • [38] Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention
    Pollak, MN
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (03) : 209 - 217
  • [39] RANSTAM J, 1991, ANTICANCER RES, V11, P2043
  • [40] Reeves GK, 2000, INT J CANCER, V89, P293, DOI 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO